Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN (SUIVICIN)
Sponsor: University Hospital, Bordeaux
A observational or N/A phase clinical study on Cervical Cancer and HPV Infection, this trial is actively recruiting participants. The trial is conducted by University Hospital, Bordeaux and has accumulated 10 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Mar 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
-
May 2023 — Jan 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
May 2022 — May 2023 [monthly]
Recruiting
-
Jan 2021 — May 2022 [monthly]
Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2019 — Oct 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Not Yet Recruiting
First recorded
Aug 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Bordeaux
For direct contact, visit the study record on ClinicalTrials.gov .